{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:20:44Z","timestamp":1648938044397},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,3,21]],"date-time":"2007-03-21T00:00:00Z","timestamp":1174435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Syst"],"published-print":{"date-parts":[[2007,3,26]]},"DOI":"10.1007\/s10916-006-9046-8","type":"journal-article","created":{"date-parts":[[2007,3,20]],"date-time":"2007-03-20T11:58:44Z","timestamp":1174391924000},"page":"117-123","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Interferon Treatment for Chronic Hepatitis C Predicted by Feature Subset Selection and Support Vector Machine"],"prefix":"10.1007","volume":"31","author":[{"given":"Jun","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anto Satriyo","family":"Nugroho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunobu","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kuroyanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,3,21]]},"reference":[{"key":"9046_CR1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJM198612183152503","volume":"315","author":"J. H. Hoofnagle","year":"1986","unstructured":"Hoofnagle, J. H., Mullen, K. D., Jones, D. B., and Rustgi, V., Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N. Engl. J. Med. 315:1575\u20131578, 1986.","journal-title":"N. Engl. J. Med."},{"key":"9046_CR2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","volume":"321","author":"G. L. Davis","year":"1989","unstructured":"Davis, G. L., Balart, L. A., Schiff, E. R., and Lindsay, K., Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N. Engl. J. Med. 321:1501\u20131506, 1989.","journal-title":"N. Engl. J. Med."},{"key":"9046_CR3","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM198911303212204","volume":"321","author":"A. M. Di Bisceglie","year":"1989","unstructured":"Di Bisceglie, A. M., Martin, P., Kassianides, C., and Lisker-Melman, M., Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N. Engl. J. Med. 321:1506\u20131510, 1989.","journal-title":"N. Engl. J. Med."},{"key":"9046_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hep.1840150108","volume":"15","author":"H. Hagiwara","year":"1992","unstructured":"Hagiwara, H., Hayashi, N., Mita, E., and Ueda, K., Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon\u2014alpha. Hepatology. 15:37\u201341, 1992.","journal-title":"Hepatology."},{"key":"9046_CR5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1053\/gast.1996.v111.pm8898645","volume":"111","author":"M. Y. Lai","year":"1996","unstructured":"Lai, M. Y., Kao, J. H., Yang, P. M., Wang, J. T., Chen, P. J., Chan, K. W, Chu, J. S., and Chen, D. S., Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology. 111:1307\u20131312, 1996.","journal-title":"Gastroenterology"},{"key":"9046_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(97)06088-1","volume":"351","author":"O. Reichard","year":"1998","unstructured":"Reichard, O., Norkrans, G., Fryden, A., Braconier, J. H., Sonnerborg, A., and Weiland O. Randomised, double-blind, placebo-controlled trial of interferon \u03b1-2b with and without ribavirin for chronic hepatitis C. Lancet. 351:83\u201387, 1998.","journal-title":"Lancet."},{"key":"9046_CR7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"M. P. Manns","year":"2001","unstructured":"Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M, Reindollar, R., Goodman, Z. D., Koury, K., Ling, M. H., and Albrecht, J. K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 358:958\u2013965, 2001.","journal-title":"Lancet."},{"key":"9046_CR8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"M. W. Fried","year":"2002","unstructured":"Fried, M. W., Schiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Goncales, F. L., H\u00e3ussinger, D., Diago, M., Carosi, G., Dhumeaux, D., Craxi, A., Lin, A., Hoffman, J., and Yu, J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347:975\u2013982, 2002.","journal-title":"N. Engl. J. Med."},{"key":"9046_CR9","unstructured":"Duda, R. O., Hart, P. E & Stork, D. G. Pattern Classification (2nd ed.). Wiley Interscience. New York, NY, 2000."},{"key":"9046_CR10","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511801389","volume-title":"An Introduction to Support Vector Machines (and other kernel-based learning methods)","author":"N. Cristianini","year":"2000","unstructured":"Cristianini, N., and Shawe-Taylor, J. An Introduction to Support Vector Machines (and other kernel-based learning methods). Cambridge University Press. 2000."},{"key":"9046_CR11","doi-asserted-by":"crossref","unstructured":"EASL Intemational Consensus Conference on hepatitis C. Paris, 26-28, February 1999 Consensus statement. Journal of Hepatology. 30(5): 956\u2013961, 1999.","DOI":"10.1016\/S0168-8278(99)80154-8"},{"key":"9046_CR12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.1840120409","volume":"12","author":"K. Kiyosawa","year":"1990","unstructured":"Kiyosawa, K., Sodeyama, T., Tanaka, E., and Gibo, Y. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 12:671\u2013675, 1990.","journal-title":"Hepatology."},{"key":"9046_CR13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199506013322202","volume":"332","author":"M. J. Tong","year":"1995","unstructured":"Tong, M. J., el-Farra, N. S., Reikes, A. R., and Co, R. L. Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 332:1463\u20131466, 1995.","journal-title":"N. Engl. J. Med."},{"key":"9046_CR14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0676.1995.tb00668.x","volume":"15","author":"K. Kanai","year":"1995","unstructured":"Kanai, K., Kako, M., Aikawa, T., and Kumada, T. Clearance of serum hepatitis C virus RNA after interferon therapy in relation to virus genotype. Liver. 15:185\u2013188, 1995.","journal-title":"Liver."},{"key":"9046_CR15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1440-1746.1997.tb00523.x","volume":"12","author":"K Kiyosawa","year":"1997","unstructured":"Kiyosawa, K. The value of hepatitis C virus genotyping to epidemiological and clinical studies. J. Gastroenterol. Hepatol. 12:623\u2013624, 1997.","journal-title":"J. Gastroenterol. Hepatol."},{"key":"9046_CR16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/hep.510250342","volume":"25","author":"K. Chayama","year":"1997","unstructured":"Chayama, K., Tsubota, A., Kobayashi, M., and Okamoto, K. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology. 25:745\u2013749, 1997.","journal-title":"Hepatology."},{"key":"9046_CR17","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/0140-6736(92)91311-U","volume":"339","author":"K. Kanai","year":"1992","unstructured":"Kanai, K., Kako, M., and Okamoto, H., HCV genotypes in chronic hepatitis C and response to interferon. Lancet. 339:1543, 1992.","journal-title":"Lancet."},{"key":"9046_CR18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/hep.1840160203","volume":"16","author":"K. Yoshioka","year":"1992","unstructured":"Yoshioka, K., Kakumu, S., Wakita, T., and Ishikawa, T. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-\u03b1 therapy: relationship to genotypes of hepatitis C virus. Hepatology. 16:293\u2013299, 1992.","journal-title":"Hepatology."},{"key":"9046_CR19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-122-3-199502010-00001","volume":"122","author":"J. B. Nousbaum","year":"1995","unstructured":"Nousbaum, J. B., Pol, S., Naloas, B., and Landais, P. Hepatitis C virus type 1b(II) infection in France and Italy. Ann. Intern. Med. 122:161\u2013168, 1995.","journal-title":"Ann. Intern. Med."},{"issue":"suppl","key":"9046_CR20","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.1002\/hep.510260721","volume":"26","author":"G. L. Davis","year":"1997","unstructured":"Davis, G. L., and Lau, J. Y. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology. 26(suppl):122S\u2013127S, 1997.","journal-title":"Hepatology."},{"key":"9046_CR21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","volume":"244","author":"G. Kuo","year":"1989","unstructured":"Kuo, G., Choo, Q. L., Alter, H. J., and Gitnick, G. L., An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:362\u2013364, 1989","journal-title":"Science."},{"key":"9046_CR22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/gast.1997.v113.pm9247476","volume":"113","author":"S. Shiratori","year":"1997","unstructured":"Shiratori, S., Kato, N., Yokosuka, O., and Imazeki, F., Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group. Gastroenterology. 113:558\u2013566, 1997.","journal-title":"Gastroenterology."},{"key":"9046_CR23","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199506013322201","volume":"332","author":"T. Poynard","year":"1995","unstructured":"Poynard, T., Bedossa, P., Chevallier, M., and Mathurin, P., A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N. Engl. J. Med. 332:1457\u20131462, 1995.","journal-title":"N. Engl. J. Med."},{"key":"9046_CR24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0140-6736(93)90635-T","volume":"341","author":"J. Y. Lau","year":"1993","unstructured":"Lau, J. Y., Davis, G. L., Kniffen, J., and Qian, K. P., Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1501\u20131504, 1993.","journal-title":"Lancet."},{"key":"9046_CR25","doi-asserted-by":"crossref","unstructured":"Bishop, C., M., Neural Networks for Pattern Recognition, Oxford University Press, 1995.","DOI":"10.1201\/9781420050646.ptb6"},{"issue":"1","key":"9046_CR26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/JCM.43.1.186-191.2005","volume":"43","author":"M. Takahashi","year":"2005","unstructured":"Takahashi, M., Saito, H., Higashimoto, M., Atsukawa, K., and Ishii, H. Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy. J. Clin Microbiol. 43(1):186\u2013191, 2005.","journal-title":"J. Clin Microbiol."},{"issue":"5","key":"9046_CR27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/14622416.7.5.697","volume":"7","author":"Y. Hwang","year":"2006","unstructured":"Hwang, Y., Chen, E. Y., Gu, Z. J., Chuang, W. L., Yu, M. L., Lai, M. Y., Chao, Y. C., Lee, C. M., Wang, J. H., Dai, C. Y., Shian-Jy Bey, M., Liao, Y. T., Chen, P. J., and Chen, D. S. Genetic predisposition of responsiveness to therapy for chronic hepatitis C. Pharmacogenomics. 7(5):697\u2013709, 2006.","journal-title":"Pharmacogenomics."},{"issue":"3","key":"9046_CR28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1440-1827.1998.tb03895.x","volume":"48","author":"S, R. Kim","year":"1998","unstructured":"Kim, S, R., Hayashi, Y., Yoon, S., Taniguchi, M., Yang, M. K., Kim, K. I., Kim, M. M., Saeki, K., Nukata, I., and Imoto, S. Prediction of efficacy of interferon treatment of chronic hepatitis C by multivariate analysis and a new classification. Pathol Int. 48(3):215\u2013220, 1998.","journal-title":"Pathol Int."}],"container-title":["Journal of Medical Systems"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-006-9046-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10916-006-9046-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-006-9046-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:46:00Z","timestamp":1559450760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10916-006-9046-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,21]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3,26]]}},"alternative-id":["9046"],"URL":"https:\/\/doi.org\/10.1007\/s10916-006-9046-8","relation":{},"ISSN":["0148-5598","1573-689X"],"issn-type":[{"value":"0148-5598","type":"print"},{"value":"1573-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,21]]}}}